These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 16532014)
1. Pre-transplantation physical and mental functioning is strongly associated with self-reported recovery from stem cell transplantation. Andorsky DJ; Loberiza FR; Lee SJ Bone Marrow Transplant; 2006 May; 37(9):889-95. PubMed ID: 16532014 [TBL] [Abstract][Full Text] [Related]
2. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [TBL] [Abstract][Full Text] [Related]
3. Quality of life associated with acute and chronic graft-versus-host disease. Lee SJ; Kim HT; Ho VT; Cutler C; Alyea EP; Soiffer RJ; Antin JH Bone Marrow Transplant; 2006 Aug; 38(4):305-10. PubMed ID: 16819438 [TBL] [Abstract][Full Text] [Related]
4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in patients undergoing allogeneic stem cell transplantation after reduced intensity conditioning versus myeloablative conditioning. Andersson I; Ahlberg K; Stockelberg D; Brune M; Persson LO Cancer Nurs; 2009; 32(4):325-34. PubMed ID: 19444087 [TBL] [Abstract][Full Text] [Related]
6. A comparative study of patient perceived quality of life pre and post coronary artery bypass graft surgery. Ballan A; Lee G Aust J Adv Nurs; 2007; 24(4):24-8. PubMed ID: 17682410 [TBL] [Abstract][Full Text] [Related]
7. IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation. Nevill TJ; Shepherd JD; Sutherland HJ; Abou Mourad YR; Lavoie JC; Barnett MJ; Nantel SH; Toze CL; Hogge DE; Forrest DL; Song KW; Power MM; Nitta JY; Dai Y; Smith CA Biol Blood Marrow Transplant; 2009 Feb; 15(2):205-13. PubMed ID: 19167680 [TBL] [Abstract][Full Text] [Related]
8. Altered sexual health and quality of life in women prior to hematopoietic cell transplantation. Tierney KD; Facione N; Padilla G; Blume K; Dodd M Eur J Oncol Nurs; 2007 Sep; 11(4):298-308. PubMed ID: 17196431 [TBL] [Abstract][Full Text] [Related]
9. The evolution of hematopoietic SCT in myelodysplastic syndrome. Kindwall-Keller T; Isola LM Bone Marrow Transplant; 2009 Apr; 43(8):597-609. PubMed ID: 19252532 [TBL] [Abstract][Full Text] [Related]
10. Quality of life and recovery after graft-versus-host disease. Baker KS; Fraser CJ Best Pract Res Clin Haematol; 2008 Jun; 21(2):333-41. PubMed ID: 18503996 [TBL] [Abstract][Full Text] [Related]
11. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Michallet M; Le QH; Mohty M; Prébet T; Nicolini F; Boiron JM; Esperou H; Attal M; Milpied N; Lioure B; Bordigoni P; Yakoub-Agha I; Bourhis JH; Rio B; Deconinck E; Renaud M; Chir Z; Blaise D Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838 [TBL] [Abstract][Full Text] [Related]
12. Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome. Nakamura R; Rodriguez R; Palmer J; Stein A; Naing A; Tsai N; Chang K; Slovak ML; Bhatia R; Spielberger R; Kogut N; Pullarkat V; Kirschbaum M; Forman SJ; O'Donnell MR Bone Marrow Transplant; 2007 Nov; 40(9):843-50. PubMed ID: 17724447 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the quality of life after conventional versus off-pump coronary artery bypass surgery. Kapetanakis EI; Stamou SC; Petro KR; Hill PC; Boyce SW; Bafi AS; Corso PJ J Card Surg; 2008; 23(2):120-5. PubMed ID: 18304125 [TBL] [Abstract][Full Text] [Related]
14. Self-reported and clinically determined oral health status predictors for quality of life in dentate older migrant adults. Mariño R; Schofield M; Wright C; Calache H; Minichiello V Community Dent Oral Epidemiol; 2008 Feb; 36(1):85-94. PubMed ID: 18205644 [TBL] [Abstract][Full Text] [Related]
15. Quality of life following allogeneic stem cell transplantation, comparing parents' and children's perspective. Forinder U; Löf C; Winiarski J Pediatr Transplant; 2006 Jun; 10(4):491-6. PubMed ID: 16712609 [TBL] [Abstract][Full Text] [Related]
16. Behavioral, social, and educational outcomes after pediatric stem cell transplantation and related factors. Barrera M; Atenafu E; Pinto J Cancer; 2009 Feb; 115(4):880-9. PubMed ID: 19130461 [TBL] [Abstract][Full Text] [Related]
17. Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial. Markova M; Barker JN; Miller JS; Arora M; Wagner JE; Burns LJ; MacMillan ML; Douek D; DeFor T; Tan Y; Repka T; Blazar BR; Weisdorf DJ Bone Marrow Transplant; 2007 Feb; 39(4):193-9. PubMed ID: 17220905 [TBL] [Abstract][Full Text] [Related]
19. Quality of life and health in children following allogeneic SCT. Forinder U; Löf C; Winiarski J Bone Marrow Transplant; 2005 Jul; 36(2):171-6. PubMed ID: 15937508 [TBL] [Abstract][Full Text] [Related]
20. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28negative CD8+ T cells on relapse. Yakoub-Agha I; Saule P; Magro L; Cracco P; Duhamel A; Coiteux V; Bruno B; Dufossé F; Jouet JP; Dessaint JP; Labalette M Biol Blood Marrow Transplant; 2009 Apr; 15(4):496-504. PubMed ID: 19285638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]